Medtronic's Surgical Robot Approaches Key Milestones

Medtronic's Surgical Robot Approaches Key Milestones

Source: 
Medical Devices and Diagnostics Industry
snippet: 

During Medtronic's recent earnings call, CEO Geoff Martha confirmed that the company is on track to submit for a CE mark and to seek an investigational device exemption from FDA for the much-anticipated soft-tissue surgical robot. The news comes about 18 months since Medtronic first unveiled the robot during an investor meeting in 2019, and is in line with the timeline the company initially shared during the reveal.